Stay updated on Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- Check4 days agoChange DetectedThis update adds new sections to the study record history and removes an older version entry, signaling ongoing updates to the trial record.SummaryDifference0.2%

- Check11 days agoChange DetectedThe footer revision label updated from v3.6.3 to v3.6.4 on the history page, indicating a new release of the ClinicalTrials.gov interface behind the page. This change reflects an underlying platform update and does not modify the study information displayed.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new Revision: v3.6.3 is shown, replacing the previous v3.6.2, indicating a small software update to the interface.SummaryDifference0.0%

- Check39 days agoChange DetectedA new version (v3.6.2) of the study record was added on 2026-06-23 with updated Study Status and Contacts/Locations. This version replaces the previous revision (v3.6.0).SummaryDifference0.2%

- Check54 days agoChange DetectedThe page adds an eligibility check ('Check who can join') and a 'Find Contact Information' option. The revision label updates from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check61 days agoChange DetectedThe footer revision tag was updated from v3.5.4 to v3.5.5, indicating a newer software release. This change is a backend/version update and does not modify study content or user-visible data.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.